Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 1998 / Cilt: 51 - Sayı: 1

Chronic immune thrombocytopenic purpura in children

Çocukta kronik immun trombositopenik purpura ( 63 hastada tedavi sonuçları )

Pages
9–15
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, we conclude that, in respect to transient and sustained remission; oral steroid, YDMP and IVIC has no superiority to each other and splenectomy is the best treatment whe sustained remission is considered.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic Immune Thrombocytopenic Purpura in Children Sixty-three chronic ITP. cases followedin our department between 1977-93 were evaluated retrospectively.
📊
Key Findings & Data:Skin and mucous membrane bleedings were in 45(71.42%) of patients and the rest had presented with epistaxes, gum and genitourinary bleeding.
💡
Conclusion & Impact:Finally, we conclude that, in respect to transient and sustained remission; oral steroid, YDMP and IVIC has no superiority to each other and splenectomy is the best treatment whe sustained remission is considered.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Chronic Immune Thrombocytopenic Purpura in Children Sixty-three chronic ITP. cases followedin our department between 1977-93 were evaluated retrospectively. Skin and mucous membrane bleedings were in 45(71.42%) of patients and the rest had presented with epistaxes, gum and genitourinary bleeding. Steroid treatment was given orally 1-2 mg/kg/day in 43 patients and as H DM P in 17. Complete sustained remission was obtanied in 6(14%) of the oral steroid and 1(5.3%) of HDMP patients. IVIC was given to 16 patients but hone achieved sustained remission. Eight patients were splenectomized and 4 had complete remission eventually. HDMP and IVIC were superior to oral steroids with respect to transient response. There were no spontaneous remissions and hone of the patients were lost due to hemorrhages or CNS bleeding. IVIG and HDMP were more effective to raise platelet counts in a short time, whereas oral steroids were more effective in obtaining sustained remission. Early initiation of steroids were observed to be a better predictor to achive sustained remission. Splenectomy should be performed in patients who are unresponsive to other treatment schemes have higher risk of bleeding. Finally, we conclude that, in respect to transient and sustained remission; oral steroid, YDMP and IVIC has no superiority to each other and splenectomy is the best treatment whe sustained remission is considered.

Özet

1977-93 yılları arasında -Kliniğimizde izlenen 63 kronik immun trombositopenik purpuralı (ITP) hasta retrospektif olarak değerlendirildi. Hastaların 45'inde (%71,42) sadece deri ve mukoza kanamaları varken geri kalanlarda ayrıca epistaksis, dişeti kanaması ve genitoüriner sistem kanamaları eşlik ediyordu. Steroid tedavisi 43 hastada oral steroid, 77 hastada yüksek doz metil prednizolon (YDMP) şeklinde yapıldı. Oral steroid uygulanan hastaların 6'sında (%14), YDMP uygulanan 77 hastanın sadece birinde (%5,3) kalıcı yanıt elde edildi. 16 hastada intravenöz immunglobulin (IVIC) uygulandı ve hiçbirinde kalıcı yanıt elde edilmedi. 8 hastaya splenektomi uygulandı, 4'ünde kalıcı yanıt elde edildi. Hiçbir hastada spontan remisyon gözlenmedi. Kanamalarla veya santral sinir sistemi kanaması ile kaybedilen hasta olmadı. Oral steroid, YDMP ve IVIG'in kalıcı ve geçici remisyon yönünden birbirlerine üstünlükleri olmadığı, splenektominin kalıcı remisyon açısından en etkin tedavi şekli olduğu sonucuna varıldı.

🔖

Cite This Article

YILDIRMAK, Y., ARCASOY, A., UYSAL, Z. (2022). Chronic immune thrombocytopenic purpura in children. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 51 - Sayı: 1, 9–15. https://ajindex.com/articles/444263

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Aronis S, Platokouki H, Mitsika A. Seventeen years of expe-rience with chronic idiopathic thrombocytopenic pur-pura in childhood. Pediatr Hemat Oncol 1994,T 1: 487-498
  2. Breardsley DS. Platelet abnormalities in infancy and child-hood. İn: Nathan DC, Oski FA. Hematology of İnfancy and Childhood 4th ed. WB Saunders Company, 1993:1561-1604
  3. Bithell TC. Thrombocytopenia caused by immunologic pla-telet destruction. İn: Lee GR, Bithell TC Foerster). Wint-robe's Clinical Hematology 9th ed. Lea&Febiger 1993:1329-1355
  4. Lusher JM, Emami A, Ravindranath Y, VVarrier Al. İdiopat-hic thrombocytopenic purpura in children. The Am J Pediatr Hemat Oncol 1984;6.:149-157
  5. Tamary H, Kaplinsky C, Levy I, Cohen IJ, Yaniv I et al. Chro-nic childhood thrombocytopenic purpura: long t'erm fol-lovv up Açta Pediatr. 1994; 83:931-934
  6. Russel EC, Maurer HM. Alternatives to splenectomy in the management of chronic idiopathic purpura in childho-od. Tha Am J Pediatr Hemat Oncol 1984; 6:175-179
  7. Branehög I, Kutti J, VVeinfeld A. Platelet survival and plate-let production in idiopathic thrombocytopenic purpura. Brit J Hemat 1974;27:127-143
  8. Berlucci S, Han ZC, Caen JP. Studies of in vitro megacaryo-poesis in adult immune thrombocytopenic purpura (ITP). EurJ Haematol 1991;47:86-90
  9. Mcmilian R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megacaryocytes in idiopathic throm-bocytopenic purpura. JAMA 1978; 239:2460-2462
  10. Pizzi F, Carrara PM, Aldeghi A, Eridani S. Immunoflorescen-ce of megacaryocytes in the thrombocytopenic purpu-ras. Blood 1966; 27:521-526
  11. Berchtold P, McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 1989; 74:2309-2317
  12. Kiefel V, Spaeth P, Mueller C. Immune thrombocytopenic purpura autoimmune or immune complex disease?. Brit J Haematol 1986; 64:57-68
  13. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D et al. The J Pediatr 1993; 123:989-995
  14. Bussel JB, Fitzgerald-Pedersen J, Feldman C. Alternation of tvvo doses of ıntravenous gammaglobulin inthe mainte-nance treatment of patients with immune thrombocyto-penic purpura. Am J Hematol 1990; 33:184-188
  15. Hoff J, Ritchey AK. Pulse methylprednisolone therapy t'or acute childhood idiopathic thrombocytopenic purpura. The ) Pediatr 1988; 113:563-566
  16. Özsoylu Ş. Bolus Methylprednisolone therapy in chronic idiopathic thrombocytopenic purpura in children
  17. Hollenberg JP, Subak LL, Ferry JJ, Bussel JB. Cost-effective-ness